FFRCT for Complex Coronary Artery Disease Treatment Planning: New Opportunities

Jonathon Leipsic1, Jonathan Weir-McCall1, Philipp Blanke1

  • 1St Paul's Hospital & University of British Columbia, Vancouver, British Columbia Vancouver, Canada.

Insights

Coronary computed tomography (CT) angiography combined with fractional flow reserve (FFRCT) now aids complex coronary artery disease management. This review explores FFRCT’s evolving role, opportunities, and remaining questions in guiding revascularization decisions.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Medical Diagnostics

Background:

  • Coronary computed tomography (CT) is established for diagnosing coronary artery disease (CAD) and risk stratification.
  • Coronary CT angiography (CCTA) has had a limited role in managing complex CAD and planning revascularization.
  • Fractional flow reserve (FFR) computed from CT angiography (FFRCT) integrates anatomical and physiological data.

Purpose of the Study:

  • To review the evolving role of FFRCT in managing complex coronary artery disease (CAD).
  • To discuss the opportunities and current data supporting FFRCT in treatment decision-making.
  • To identify unanswered questions regarding FFRCT in complex CAD management.

Main Methods:

  • Review of current literature on FFRCT in complex coronary artery disease.
  • Analysis of studies combining CCTA with FFRCT for lesion-specific pressure loss assessment.
  • Evaluation of FFRCT's impact on revascularization strategies.

Main Results:

  • FFRCT enables simultaneous assessment of coronary anatomy and physiology.
  • It allows for adjudication of lesion-specific pressure loss, improving treatment guidance.
  • The integration of CCTA and FFRCT shows potential in informing complex CAD management.

Conclusions:

  • FFRCT represents a significant advancement in non-invasive assessment of complex coronary artery disease.
  • Combined CCTA and FFRCT offers a powerful tool for guiding revascularization decisions.
  • Further research is needed to address remaining questions and optimize its clinical application.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K